Study of Four-factor Prothrombin Complex Concentrate, OCTAPLEX, in Patients With Acute Major Bleeding on Direct Oral Anticoagulant (DOAC) Therapy With Factor Xa Inhibitor
Latest Information Update: 13 Jun 2024
At a glance
- Drugs Prothrombin complex concentrate (Primary)
- Indications Surgical blood loss
- Focus Registrational; Therapeutic Use
- Sponsors Octapharma
- 28 Feb 2024 Planned number of patients changed from 200 to 260.
- 28 Feb 2024 Planned End Date changed from 1 Feb 2024 to 1 Dec 2024.
- 28 Feb 2024 Planned primary completion date changed from 1 Jan 2024 to 1 Dec 2024.